Resource recovery from source separated domestic waste(water) streams; full scale results

A major fraction of nutrients emitted from households are originally present in only 1% of total wastewater volume. New sanitation concepts enable the recovery and reuse of these nutrients from feces and urine. Two possible sanitation concepts are presented, with varying degree of source separation leading to various recovery products. Separate vacuum collection and transport followed by anaerobic treatment of concentrated black water (BW) demonstrated on a scale of 32 houses preserve 7.6 g/N/p/d and 0.63 gP/p/d amounting to respectively 69 and 48% of the theoretically produced N and P in the household, and 95% of the retained P was shown to be recoverable via struvite precipitation. Reuse of the anaerobic sludge in agriculture can substantially increase the P recovery. Energy recovery in the form of biogas from anaerobic digestion of concentrated BW, fits well in new concepts of sustainable, zero energy buildings. Nutrient recovery from separately collected urine lowers the percentage of nutrient recovery in comparison with BW but can, on the other hand, often be implemented in existing sanitation concepts. Theoretically 11gN/p/d and 1.0 g P/p/d are produced with urine, of which 38-63 and 34-61% were recovered in practice on a scale of 8-160 inhabitants in Sweden. New sanitation concepts with resource recovery and reuse are being demonstrated worldwide and more and more experience is being gained.     

Perceptions of the health and convenience characteristics of fresh and dried fruits

Dried fruits consumption has not received much research attention, although these foods are associated with potential health benefits. Therefore, the aim of this study was to compare fresh fruits and dried fruits on measures of health, convenience and consumer feelings.An on-line questionnaire that measured consumers' perceptions of the health benefits and convenience characteristics and their feelings about the consumption of both fresh fruits (apples and plums) and dried fruits (e.g., raisins, dates, and apricots) was completed by 693 respondents (Polish, French, and Dutch).Generally, fresh fruits were perceived to be healthier and less convenient than dried fruits. Consumers also reported more positive feelings about the consumption of fresh fruits compared to dried fruits. The more that the respondents were willing to sacrifice for their health, the more positively they rated the health aspects of both fresh and dried fruits, as well as several perceptions of convenience of both fresh and dried fruits. Health preoccupation was unrelated to most of the convenience perceptions and was associated with lower scores on several perceptions of healthiness. Recommendations for the consumer-oriented development of dried fruits are also provided.     

Studies on the usefulness of Cucurbita maxima for the production of ready-to-eat dried vegetable snacks with a high carotenoid content

Recent research indicates a beneficial influence of a diet rich in β-carotene on human health. For that reason, experiments were undertaken to process winter squash with a high carotenoid content into ready-to-eat dried snacks. Sensory quality and dietary value of chips and crispy cubes made from different cultivars were investigated.The suitability of winter squash for drying purposes depended mainly on the dry matter content in the raw material. Although all the investigated cultivars can be used for producing chips, obtaining high quality porous cubes requires at least 15% of dry matter. ‘Justynka F1’ emerged as the most suitable cultivar for processing; both chips and cubes produced from its fruits were characterized by a high sensory quality and contained significant amounts of beta-carotene (225- 253 μg g-1). Also, the cultivar ‘Amazonka’ could be considered for the production of chips as it allowed us to obtain a product with a high beta-carotene content (200 μg g-1) and good sensory properties. The dried ready-to-eat crispy vegetable snacks made from the new cultivars of winter squash could be exploited as a novel attractive product with the attractive taste and colour to serve as a valuable source of carotenoids in human diet.     

Genetic Background of Fetal Growth Restriction

Fetal growth restriction (FGR) is one of the most formidable challenges in present-day antenatal care. Pathological fetal growth is a well-known factor of not only in utero demise in the third trimester, but also postnatal morbidity and unfavorable developmental outcomes, including long-term sequalae such as metabolic diseases, diabetic mellitus or hypertension. In this review, the authors present the current state of knowledge about the genetic disturbances responsible for FGR diagnosis, divided into fetal, placental and maternal causes (including preeclampsia), as well as their impact on prenatal diagnostics, with particular attention on chromosomal microarray (CMA) and noninvasive prenatal testing technique (NIPT).     

Zapotin,a Polymethoxyflavone,with Potential Therapeutic Attributes

The use of plants as traditional medicines is common and has prevailed in many different cultures over time. Polymethoxyflavones (PMFs) are natural polyphenols from the group of flavonoids. Zapotin, a member of the PMFs, is found mainly in citrus plants and is almost exclusively limited to their peels. The chemical structure of zapotin has been questioned from the very beginning, since the structure of flavonoids with a single oxygen atom in the C2′ position is extremely rare in the plant kingdom. To clarify this, the structural determination and bio-inspired synthesis of zapotin are discussed in detail in this review. Due to the broad biological potential of PMFs, the complication in the isolation process and characterization of PMFs, as well as their purification, have been estimated by adapting various chromatographic methods. According to available data from the literature, zapotin may be a promising curative agent with extensive biological activities, especially as a chemopreventive factor. Apart from that, zapotin acts as an antidepressant-like, anticancer, antifungal, and antioxidant agent. Finally, accessible studies about zapotin metabolism (absorption, distribution, metabolism, excretion, and toxicity) underline its potential in use as a therapeutic substance.     

Investigation of doped-gadolinium zirconate nanomaterials for high-temperature hydrogen sensor applications

The incorporation of selective nanomaterials, such as common metal oxide semiconductor compositions, into resistive-type gas sensors has been shown by many researchers to lead to very high sensitivities and response rates, especially for micro-sized chemical sensors for room-temperature applications. The same strategy utilizing sensing nanomaterials has not been demonstrated for high-temperature sensors due to the intrinsic instability of typical metal oxide semiconductor nanomaterials at temperatures >500 °C. Within this work, doped Gd₂Zr₂O₇ (GZO) nanomaterial compositions were investigated for H₂ resistive-type sensors for applications between 600 and 1000 °C. This paper investigates the mechanism of H₂ sensing for doped GZO nanomaterials and SnO₂/GZO nanocomposites at the elevated temperatures. By integrating 10 vol.% nano-SnO₂ into yttrium-doped GZO nanomaterials, a sensitivity of 4.15 % was retained for 4000 ppm H₂ levels with a low signal drift of 0.42 %/h at 1000 °C in a 20 % O₂/N₂ gas stream. The signal drift was reduced by more than half of that compared to pure nano-SnO₂ at the same conditions. The nano-GZO limited the grain growth of the nano-SnO₂ particles and also prevented the nano-SnO₂ from fully reducing to Sn at high temperatures in a low oxygen atmosphere. It is among the first resistive-type sensors operating at 1000 °C with sensing times of <5 min. This demonstration provided an example of a strategy of combining traditional metal oxide semiconductor and refractory nanomaterial compositions to form sensing nanocomposites with new sensing mechanisms, as well as, enhanced chemical and microstructural stabilities in high-temperature environments.     

Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists

The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney disease (DKD) remains one of the leading long-term complications of T2D. Several lines of evidence indicate that glucose-lowering agents prevent the onset and progression of DKD in its early stages but are of limited efficacy in later stages of DKD. However, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor (GLP-1R) agonists were shown to exert nephroprotective effects in patients with established DKD, i.e., those who had a reduced glomerular filtration rate. These effects cannot be solely attributed to the improved metabolic control of diabetes. In our review, we attempted to discuss the interactions of both groups of agents with inflammation and oxidative stress—the key pathways contributing to organ damage in the course of diabetes. SGLT2i and GLP-1R agonists attenuate inflammation and oxidative stress in experimental in vitro and in vivo models of DKD in several ways. In addition, we have described experiments showing the same protective mechanisms as found in DKD in non-diabetic kidney injury models as well as in some tissues and organs other than the kidney. The interaction between both drug groups, inflammation and oxidative stress appears to have a universal mechanism of organ protection in diabetes and other diseases.     

Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary Epithelial Ovarian Cancer

Recent findings on the molecular basis of ovarian cancer development and progression create new opportunities to develop anticancer medications that would affect specific metabolic pathways and decrease side systemic toxicity of conventional treatment. Among new possibilities for cancer chemoprevention, much attention is paid to curcumin—A broad-spectrum anticancer polyphenolic derivative extracted from the rhizome of Curcuma longa L. According to ClinicalTrials.gov at present there are no running pilot studies, which could assess possible therapeutic benefits from curcumin supplementation to patients with primary epithelial ovarian cancer. Therefore, the goal of this review was to evaluate potential preclinical properties of curcumin and its new analogues on the basis of in vivo and in vitro ovarian cancer studies. Curcumin and its different formulations have been shown to display multifunctional mechanisms of anticancer activity, not only in platinum-resistant primary epithelial ovarian cancer, but also in multidrug resistant cancer cells/xenografts models. Curcumin administered together with platinum-taxane chemotherapeutics have been reported to demonstrate synergistic effects, sensitize resistant cells to drugs, and decrease their biologically effective doses. An accumulating body of evidence suggests that curcumin, due to its long-term safety and an excellent profile of side effects should be considered as a beneficial support in ovarian cancer treatment strategies, especially in patients with platinum-resistant primary epithelial recurrent ovarian cancer or multidrug resistant disease. Although the prospect of curcumin and its formulations as anticancer agents in ovarian cancer treatment strategy appears to be challenging, and at the same time promising, there is a further need to evaluate its effectiveness in clinical studies.